Gladstone NOW: The Campaign Join Us on the Journey ✕
676 - 690 of 1459 Results Clear All
Two Gladstone scientist share their recent COVID-19 research
Graduate Students and Postdocs COVID-19 Conklin Lab McDevitt Lab
Tyrone Porter offers his best prescription for confronting what can often be a silent burden and putting a stop to the cultural tax many pay.
Communications Diversity
USA Today—Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, shares her view of CRISPR-based coronavirus detection kits and the possibility they might be deployed during the current pandemic. She and Senior Investigator Melanie Ott, MD, PhD, recently described the test they developed together in a publication posted on the electronic preprint platform bioRxiv.
Gladstone Experts COVID-19 Data Science and Biotechnology Infectious Disease Doudna Lab Ott Lab CRISPR/Gene Editing
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, endorses presidential candidate Joe Biden's plan to fight the coronavirus pandemic, calling the plan “rational.”
Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab
Celebrate Halloween from the comfort of your own home. Gladstone’s Art Department has designed these ghastly coloring sheets for the young or young at heart.
The Dolby family has supported Gladstone research since 2015
Donor Stories Alzheimer’s Disease
San Francisco Chronicle—Some of the treatments the president received for COVID-19 were developed using cells derived from human embryonic tissue. In addition, many of the COVID-19 vaccine candidates were developed using fetal cell lines. Gladstone Senior Investigator Warner Greene explains how valuable fetal tissue research has been to research on cancer, HIV, spinal cord injuries, and many other diseases. He also describes how the president’s 2019 decision to cut federal funding for fetal cell research has damaged that progress.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
abc News—In 2019, the Trump administration suspended federal funding for research involving fetal tissue. Gladstone President Deepak Srivastava explains that if the funding ban had been in place over the last few decades, many important drugs—including treatments for COVID-19—would not have been developed.
Gladstone Experts COVID-19 Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs
Science is Fun!—Director of the Gladstone Institute of Virology Melanie Ott describes her latest work developing a CRISPR-based test for COVID-19, and the prospect for broadly acting antiviral therapeutics.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
Benoit Bruneau and Katie Pollard study DNA folding to identify the genetic causes of congenital heart disease
Grants News Release Congenital Heart Disease Cardiovascular Disease Data Science and Biotechnology Bruneau Lab Pollard Lab
The 2020 Berkelhammer Scholars break new ground in research on dementias, Parkinson’s disease, and neuropsychiatric disorders
Donor Stories Parkinson’s Disease Alzheimer’s Disease Dementia Neurological Disease Akassoglou Lab Kreitzer Lab Mahley Lab Mucke Lab Nakamura Lab
abc News—Gladstone President Deepak Srivastava, MD, comments on the fact that the experimental treatments President Trump received for COVID-19 were tested on cells that were derived from fetal tissue decades ago, and expresses concern that the Trump administration's current ban on the use of fetal tissue for research could slow efforts to curb the pandemic.
Gladstone Experts COVID-19 Cardiovascular Disease Srivastava Lab
Learn how a Gladstone bioinformatician is spending his days during shelter-in-place
Profile Bioinformatics Core Finkbeiner Lab
Jim Allison spoke along side a panel of experts in cancer immunotherapy.
Postdoctoral and Graduate Student Education and Research Development Affairs Postdoc Advisory Committee Graduate Students and Postdocs
Gladstone celebrates inspiring women in STEM
Womens Initiative Diversity
